⌕
Agios Pharmaceuticals · AGIO · Nasdaq
Tenet 64 · Solid
Compare
$31.59−0.54%At closeTenet 64 · Solid
$31.59−0.17 (−0.54%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Agios Pharmaceuticals (AGIO) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice

27 figures withheld by our checks. Each blank figure names its reason.

85
VALUE
Low multiples vs sector
discount to its peers
41
QUALITY
Weak
below-peer returns
85
HEALTH
Sturdy
conservative balance sheet
47
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A weak business at low multiples for its sector: value 85, quality 41, health 85, growth 47, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
85th pctilediscount to its peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.—Not reported in the company's filings for this period.
P/E—Not meaningful: the company made a loss.
P/B1.985th pctile
P/FCF—Not meaningful: the denominator is zero or negative.
EV / EBITDA—Not meaningful: EBITDA is zero or negative.
85th pctileconservative balance sheet
Current ratio9.6985th pctile
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.8.4583rd pctile
Net debt / EBITDA(Total debt − cash) ÷ EBITDA—Not meaningful: EBITDA is zero or negative.
Interest coverage—Not meaningful: operating income is zero or negative.
Debt / equity0.0087th pctile
41st pctilebelow-peer returns
ROIC−43%16th pctile
ROE−33%24th pctile
Gross margin93.8%90th pctileown record too short
Net margin−264.8%6th pctileown record too short
Income quality (CFO/NI)—Not meaningful: the company made a loss.
Piotroski F3 / 921st pctileown record too short
Altman Z11.985th pctile
47th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin−238.5%6th pctileown record too short
the receipts behind the numbers above
Greenblatt earnings yield—EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC−43%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 313 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 13, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.